Prostate Cancer Canada Supports Innovation with Awarding of Movember Discovery Grants
Toronto, ON – Aug 14, 2014 – As part of our ongoing strategic commitment to prostate cancer research, Prostate Cancer Canada (PCC) is proud to announce the recipients of the 2014 Movember Discovery Grants, awarded by PCC, funded by Movember. This program allows both junior investigators at the start of their research careers and more established investigators to pursue important new directions in prostate cancer research. Each recipient of the Movember Discovery Grant will receive up to $200,000 in funding over a two-year term.
Prostate Cancer Canada awards $5 million in Movember funds
Toronto, ON – July 15, 2014 – Prostate Cancer Canada (PCC) is proud to announce the recipients of the $5 million 2014 Movember Team Grant. The grant, awarded by PCC and funded by Movember, rewards innovation and collaboration in a single research team from a variety of institutions across Canada.
BC Scientist’s Sweet Discovery Lands Major Prostate Cancer Research Award
Vancouver, BC – July 8, 2014 – British Columbia’s researchers are internationally renowned for their cutting-edge work in prostate cancer research, and their win streak continues with Prostate Cancer Canada’s (PCC) announcement of a new $450,000 research grant to Dr. Mads Daugaard, a senior research scientist with the Vancouver Prostate Centre.
Prostate Cancer Canada advocates for Ontario to pay for prostate cancer screening
TORONTO – June 25, 2014 This June, during the provincial election, Prostate Cancer Canada (PCC) launched an advocacy campaign that resonated with constituents across the province. The issue? Ontario is one of only two provinces that do not cover the cost of the prostate cancer screening PSA test. Using the online tool psatestsforontario.ca, PCC asked the public to make their voices heard to protest this inequality, and the results speak for themselves.
Over 27,000 Canadians Do it for Dads and Raise $2 Million for Prostate Cancer
TORONTO, June 16, 2014 – Prostate Cancer Canada’s Do it for Dads movement raised a total of nearly $2 million for prostate cancer research and support programs thanks to over 27,000 Canadians who participated this June. As part of Do it for Dads, Canadians took part in the Walk Run, Step Up Challenge and other special events in the weeks leading up to Father’s Day; they also shared photos and stories of their Dads on the Faces of Father’s Day mosaic, a photo collage that collected nearly 1,500 tributes.
Canadians Do it for Dads on Father's Day
TORONTO, June 12, 2014 - Prostate Cancer Canada and Safeway have launched an in store campaign dedicated to raising funds for cutting edge research and providing support for families living with the disease. More than $12 million has been raised by Safeway stores across Western Canada and North Western Ontario in the past decade, having a tremendous impact on the prostate cancer cause.
New research to determine low-risk from high-risk prostate cancer
Edmonton, AB – April 30, 2014 – Today Prostate Cancer Canada announced a national research funding initiative aimed at identifying prostate cancer patients who need to be treated aggressively and those who do not. Three major research teams in Edmonton, Toronto and Sherbrooke will receive close to $5 million for projects that will help prevent the overtreatment of prostate cancer. This funding is made possible due to the Movember Foundation.
New test developed to detect men at high risk of prostate cancer recurrence
Vienna, Austria: A new genetic “signature” to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday).
CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be
Toronto, ON – March 10, 2014 – There is no disputing a cancer diagnosis is among the worst news a person or their family could receive. But there is another harsh reality for many patients in Ontario and Atlantic Canada who face uncertainty and financial hardship as a result of discrimination when it comes to accessing effective cancer treatments that are taken orally. An unprecedented unification of more than 30 Canadian patient groups, physicians and health care charities, led by Kidney Cancer Canada, are working together to ensure all Canadian cancer patients have CanCertainty (www.CanCertaintyForAll.ca) – certainty that if cancer strikes them or a loved one they will have fair and equal access to the treatment they need, whether intravenous (IV) or oral.